Dean Schorno is the founder of Rigel Pharmaceuticals. Schorno is the Executive Vice President and Chief Financial Officer (CFO) of Rigel Pharmaceuticals Inc.
Dean L. Schorno is the Executive Vice President and Chief Financial Officer (CFO) of Rigel Pharmaceuticals Inc. He is responsible for managing insider stock option exercises and tax-related share transactions. Following a June 2026 stock option exercise, Schorno directly held 78,790 shares of Rigel common stock.
Full founder directory · Investor directory · Company funding database · Fundraising library